Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neurim Pharma Insomnia Drug Gets EC Approval
Neurim said that the drug has already been approved by European Medicines Agency (EMA), the Australian Therapeutic Goods Administration (TGA), the Swiss Agency for Therapeutic Products (SwissMedic) and
Neurim said that the drug has already been approved by European Medicines Agency (EMA), the Australian Therapeutic Goods Administration (TGA), the Swiss Agency for Therapeutic Products (SwissMedic) and
Teijin Chemicals has commenced selling two types of transparent conductive films: SS120 and HP125. SS120 uses polycarbonate (PC) film as substrate, and HP125 uses polyethylene terephthalate (PET) film
Kamada claimed that Glassia is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market. Kamada said
Butrans is available in three strengths 5, 10, and 20mcg/hour, each single patch is intended to be worn for seven days. Butrans Transdermal System’s active ingredient is buprenorphine,
Clinuvel claimed that its Scenesse is delivered as a subcutaneous injectable implant, works by mimicking the body’s tanning response without the need for UV exposure which causes damage
Effexor XR (venlafaxine HCl) extended-release capsules are indicated for the treatment of depression, generalised anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder (PD) with or without
As per the terms of the amendment, GSK is expected to take up the responsibility for developing Ofatumumab in autoimmune indications while continuing to jointly develop Ofatumumab with
PharmaPros said that eClinical OnDemand offers clients as an option to incorporate other data sources such as central laboratories and imaging centers, as well as 3rd party EDC,
Rivastigmine tartrate is suggested for treatment of mild to moderate Alzheimer’s dementia and mild to moderate Parkinson’s disease dementia. Caraco Pharma Rivastigmine tartrate capsules are available in 1.5mg,
Genentech’s ICON7 study is a multicenter, randomised, open-label, Phase III study in 1,528 women with previously untreated epithelial ovarian, primary peritoneal or fallopian tube carcinoma. The primary endpoint